Antiapoptotic effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant in H9c2 rat cardiomyocytes
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Granulocyte colony-stimulating factor (G-CSF) is used for heart failure therapy and promotes myocardial regeneration by inducing mobilization of bone marrow stem cells to the injured heart after myocardial infarction; however, this treatment has one weakness in that its biological effect is transient. In our previous report, we generated 5 mutants harboring N-linked glycosylation to improve its antiapoptotic activities. Among them, one mutant (Phe140Asn) had higher cell viability than wild-type hG-CSF in rat cardiomyocytes, even after treatment with an apoptotic agent (H2O2). Cells treated with this mutant significantly upregulated the antiapoptotic proteins, and experienced reductions in caspase 3 activity and PARP cleavage. Moreover, the total number of apoptotic cells was dramatically lower in cultures treated with mutant hG-CSF. Taken together, these results suggest that the addition of an N-linked glycosylation was successful in improving the antiapoptotic activity of hG-CSF, and that this mutated product will be a feasible therapy for patients who have experienced heart failure. [BMB Reports 2012; 45(12): 742-747]
Abstract
Granulocyte colony-stimulating factor (G-CSF) is used for heart failure therapy and promotes myocardial regeneration by inducing mobilization of bone marrow stem cells to the injured heart after myocardial infarction; however, this treatment has one weakness in that its biological effect is transient. In our previous report, we generated 5 mutants harboring N-linked glycosylation to improve its antiapoptotic activities. Among them, one mutant (Phe140Asn) had higher cell viability than wild-type hG-CSF in rat cardiomyocytes, even after treatment with an apoptotic agent (H2O2). Cells treated with this mutant significantly upregulated the antiapoptotic proteins, and experienced reductions in caspase 3 activity and PARP cleavage. Moreover, the total number of apoptotic cells was dramatically lower in cultures treated with mutant hG-CSF. Taken together, these results suggest that the addition of an N-linked glycosylation was successful in improving the antiapoptotic activity of hG-CSF, and that this mutated product will be a feasible therapy for patients who have experienced heart failure. [BMB Reports 2012; 45(12): 742-747]
참고문헌 (33)
- Takano, H., "Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction", J. Mol. Med., 84, pp.185~193 (2006)
- Minatoguchi, S., "Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment", Circulation, 109, pp.2572~2580 (2004)
- Orlic, D., "Mobilized bone marrow cells repair the infarcted heart, improving function and survival", Proc. Natl. Acad. Sci. U.S.A., 98, pp.10344~10349 (2001)
- Harada, M., "G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes", Nat. Med., 11, pp.305~311 (2005)
- Martin-Christin, F., "Granulocyte colony stimulating factors: how different are they? How to make a decision?", Anticancer. Drugs., 12, pp.185~191 (2001)
- Mallat, Z., "Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure", Circulation, 97, pp.1536~1539 (1998)
- Hill, M. F., "Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats", Am. J. Pathol., 148, pp.291~300 (1996)
- Eguchi, M., "Leptin protects H9c2 rat cardiomyocytes from H2O2-induced apoptosis", FEBS J., 275, pp.3136~3144 (2008)
- Liu, J., "ERKs", p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes, 2008, pp.295, H1956~H1965
- Souza, L. M., "Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells", Science, 232, pp.61~65 (1986)
- Kubota, N., "Structural characterization of natural and recombinant human granulocyte colony-stimulating factors", J. Biochem., 107, pp.486~492 (1990)
- Gervais, V., "NMR investigations of the role of the sugar moiety in glycosylated recombinant human granulocyte-colony-stimulating factor", Eur. J. Biochem., 247, pp.386~395 (1997)
- Cumming, D. A., "Glycosylation of recombinant protein therapeutics: control and functional implications", Glycobiology, 1, pp.115~130 (1991)
- Hee Kyoung Chung, "Enhanced biological effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant, on HL60 cells", BMB Reports, 44(10), pp.686~691 (2011), 생화학분자생물학회
- Lu, H. S., "Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor", Arch. Biochem. Biophys., 268, pp.81~92 (1989)
- Ishikawa, M., "The substitution of cysteine 17 of recombinant human G-CSF with alanine greatly enhanced its stability", Cell Struct. Funct., 17, pp.61~65 (1992)
- Bishop, B., "Reengineering granulocyte colony-stimulating factor for enhanced stability", J. Biol. Chem., 276, pp.33465~33470 (2001)
- Tarentino, A. L., "Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase F", Biochemistry, 24, pp.4665~4671 (1985)
- Chu, F. K., "Requirements of cleavage of high mannose oligosaccharides in glycoproteins by peptide N-glycosidase F", J. Biol. Chem., 261, pp.172~177 (1986)
- Umemoto, J., "Purification and properties of an endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae", J. Biol. Chem., 252, pp.8609~8614 (1977)
- Wang, Z., "Angiopoietin-1 protects H9c2 cells from H2O2-induced apoptosis through AKT signaling", Biochem. Biophys. Res. Commun., 359, pp.685~690 (2007)
- Takano, H., "G-CSF therapy for acute myocardial infarction", Trends. Pharmacol. Sci., 28, pp.512~517 (2007)
- Kornfeld, R., "Assembly of asparagine- linked oligosaccharides", Annu. Rev. Biochem., 54, pp.631~664 (1985)
- Van den Steen, P., "Concepts and principles of O-linked glycosylation", Crit. Rev. Biochem. Mol. Biol., 33, pp.151~208 (1998)
- Burda, P., "The dolichol pathway of N-linked glycosylation", Biochim. Biophys. Acta., 1426, pp.239~257 (1999)
- Munro, S., "What can yeast tell us about N-linked glycosylation in the Golgi apparatus?", FEBS Lett., 498, pp.223~227 (2001)
- Oheda, M., "Structures of the sugar chains of recombinant human granulocyte- colony-stimulating factor produced by Chinese hamster ovary cells", J. Biochem., 103, pp.544~546 (1988)
- Clogston, C. L., "Glycosidase digestion, electrophoresis and chromatographic analysis of recombinant human granulocyte colony-stimulating factor glycoforms produced in Chinese hamster ovary cells", J. Chromatogr., 637, pp.55~62 (1993)
- Tamada, T., "Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex", Proc. Natl. Acad. Sci. U.S.A., 103, pp.3135~3140 (2006)
- Okazaki, T., "Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes", Am. J. Pathol., 171, pp.1093~1103 (2007)
- Pacher, P., "Role of poly(ADP-ribose) polymerase1 (PARP-1) in cardiovascular diseases: the therapeuticpotential of PARP inhibitors", Cardiovasc. Drug. Rev., 25, pp.235~260 (2007)
- Ungvari, Z., "Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure", Curr. Vasc. Pharmacol., 3, pp.221~229 (2005)
- Pacher, P., "Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure", J. Pharmacol. Exp. Ther., 300, pp.862~867 (2002)
